Nantong Haiers Pharmaceutical

Nantong Haiers Pharmaceutical is a China-based pharmaceutical company that focuses on the development and production of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company's portfolio primarily includes small molecule generics targeting prevalent conditions such as hypertension, type 2 diabetes, and various bacterial infections. With manufacturing facilities located in the Nantong Economic and Technological Development Zone, the firm adheres to international GMP standards to ensure product quality for both domestic and export markets. In addition to its own product line, Nantong Haiers provides contract manufacturing (CMO) and development services to other pharmaceutical entities. The company is recognized as a high-tech enterprise in Jiangsu Province, emphasizing continuous improvement in its chemical synthesis and formulation processes. Its commitment to quality and innovation has established it as a reliable supplier in the global pharmaceutical supply chain.